Global Dry Powder Inhalation Device Market Growth 2025-2031
Description
The global Dry Powder Inhalation Device market size is predicted to grow from US$ 1654 million in 2025 to US$ 2519 million in 2031; it is expected to grow at a CAGR of 7.3% from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
A dry powder inhalation device is a medical device that drives drug powder into the respiratory tract through the patient's active inhalation. Its core design concept is to use the patient's own respiratory airflow to achieve drug delivery without propellant.
Market Concentration and Key Players:
Internationally, the market concentration of dry powder inhalers is relatively high, mainly concentrated on Europe, America and other developed countries. For example, large manufacturers such as GSK, AstraZeneca and Boehringer Ingelheim; from the domestic perspective, dry powder inhalers still have great development space in China.
Manufacturing Process and Market Trends:
The manufacturing process of dry powder inhalers revolves around drug micronization, carrier optimization and device design. The core processes include jet milling, spray drying and supercritical fluid technology, among which the new spray freeze-drying method forms amorphous powder through rapid solidification at low temperature, and combines with reverse gas chromatography to accurately control the surface energy and humidity sensitivity of the powder. The particle size of micronized drug needs to be controlled within 1-5μm to optimize lung deposition. Carriers such as lactose solve the agglomeration problem through electrostatic repulsion and anti-condensation design. The multi-dose reservoir device adopts intelligent filling line to realize efficient production of 100,000 vials per hour. For example, the Ellipta inhaler synchronizes blister foil peeling with dose counting through a precision mechanical structure, ensuring a delivered dose error rate of less than 5%.
At the market level, the global and China share increased. Drivers include a chronic obstructive pulmonary disease patient base of more than 350 million patients, an increased proportion of biologics delivery demand, and intelligent devices integrated with sensors to monitor medication compliance. In terms of technical trend, flexible electronics and 3D printing are integrated to develop curved atomizing nozzle, the detection sensitivity of graphene sensor is improved, and degradable materials reduce environmental burden. At the policy end, China has included 4 types of inhalants into medical insurance through centralized procurement policy to accelerate the process of domestic substitution, such as breaking the import monopoly of healthy budesonide suspension. In the regional market, Southeast Asia shows a super-high growth rate due to the increase of medical investment, becoming a new focus of international pharmaceutical enterprise layout.
LP Information, Inc. (LPI) ' newest research report, the “Dry Powder Inhalation Device Industry Forecast” looks at past sales and reviews total world Dry Powder Inhalation Device sales in 2024, providing a comprehensive analysis by region and market sector of projected Dry Powder Inhalation Device sales for 2025 through 2031. With Dry Powder Inhalation Device sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Dry Powder Inhalation Device industry.
This Insight Report provides a comprehensive analysis of the global Dry Powder Inhalation Device landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Dry Powder Inhalation Device portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Dry Powder Inhalation Device market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Dry Powder Inhalation Device and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Dry Powder Inhalation Device.
This report presents a comprehensive overview, market shares, and growth opportunities of Dry Powder Inhalation Device market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Single Dose
Multiple Doses
Storage Type
Segmentation by Application:
Asthmatic
COPD
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Catalent
AptarGroup
H&T Presspart
Vectura Delivery Devices
MannKind Corporation
MicroDose Therapeutx
GSK
Novartis
AstraZeneca
Boehringer Ingelheim
Orion Pharma
Liquidia Technologies
Teva Pharmaceutical Industries
Chiesi
Hovione
Nemera
Dürr
Shanghai Huarui
Hangzhou Changxi Pharmaceutical
Suzhou Inha Medicine
Shenzhen Resproly Biopharmaceuticals
Key Questions Addressed in this Report
What is the 10-year outlook for the global Dry Powder Inhalation Device market?
What factors are driving Dry Powder Inhalation Device market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Dry Powder Inhalation Device market opportunities vary by end market size?
How does Dry Powder Inhalation Device break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
A dry powder inhalation device is a medical device that drives drug powder into the respiratory tract through the patient's active inhalation. Its core design concept is to use the patient's own respiratory airflow to achieve drug delivery without propellant.
Market Concentration and Key Players:
Internationally, the market concentration of dry powder inhalers is relatively high, mainly concentrated on Europe, America and other developed countries. For example, large manufacturers such as GSK, AstraZeneca and Boehringer Ingelheim; from the domestic perspective, dry powder inhalers still have great development space in China.
Manufacturing Process and Market Trends:
The manufacturing process of dry powder inhalers revolves around drug micronization, carrier optimization and device design. The core processes include jet milling, spray drying and supercritical fluid technology, among which the new spray freeze-drying method forms amorphous powder through rapid solidification at low temperature, and combines with reverse gas chromatography to accurately control the surface energy and humidity sensitivity of the powder. The particle size of micronized drug needs to be controlled within 1-5μm to optimize lung deposition. Carriers such as lactose solve the agglomeration problem through electrostatic repulsion and anti-condensation design. The multi-dose reservoir device adopts intelligent filling line to realize efficient production of 100,000 vials per hour. For example, the Ellipta inhaler synchronizes blister foil peeling with dose counting through a precision mechanical structure, ensuring a delivered dose error rate of less than 5%.
At the market level, the global and China share increased. Drivers include a chronic obstructive pulmonary disease patient base of more than 350 million patients, an increased proportion of biologics delivery demand, and intelligent devices integrated with sensors to monitor medication compliance. In terms of technical trend, flexible electronics and 3D printing are integrated to develop curved atomizing nozzle, the detection sensitivity of graphene sensor is improved, and degradable materials reduce environmental burden. At the policy end, China has included 4 types of inhalants into medical insurance through centralized procurement policy to accelerate the process of domestic substitution, such as breaking the import monopoly of healthy budesonide suspension. In the regional market, Southeast Asia shows a super-high growth rate due to the increase of medical investment, becoming a new focus of international pharmaceutical enterprise layout.
LP Information, Inc. (LPI) ' newest research report, the “Dry Powder Inhalation Device Industry Forecast” looks at past sales and reviews total world Dry Powder Inhalation Device sales in 2024, providing a comprehensive analysis by region and market sector of projected Dry Powder Inhalation Device sales for 2025 through 2031. With Dry Powder Inhalation Device sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Dry Powder Inhalation Device industry.
This Insight Report provides a comprehensive analysis of the global Dry Powder Inhalation Device landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Dry Powder Inhalation Device portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Dry Powder Inhalation Device market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Dry Powder Inhalation Device and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Dry Powder Inhalation Device.
This report presents a comprehensive overview, market shares, and growth opportunities of Dry Powder Inhalation Device market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Single Dose
Multiple Doses
Storage Type
Segmentation by Application:
Asthmatic
COPD
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Catalent
AptarGroup
H&T Presspart
Vectura Delivery Devices
MannKind Corporation
MicroDose Therapeutx
GSK
Novartis
AstraZeneca
Boehringer Ingelheim
Orion Pharma
Liquidia Technologies
Teva Pharmaceutical Industries
Chiesi
Hovione
Nemera
Dürr
Shanghai Huarui
Hangzhou Changxi Pharmaceutical
Suzhou Inha Medicine
Shenzhen Resproly Biopharmaceuticals
Key Questions Addressed in this Report
What is the 10-year outlook for the global Dry Powder Inhalation Device market?
What factors are driving Dry Powder Inhalation Device market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Dry Powder Inhalation Device market opportunities vary by end market size?
How does Dry Powder Inhalation Device break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
157 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for Dry Powder Inhalation Device by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for Dry Powder Inhalation Device by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
